CoChat

The WNT antagonist Dickkopf2 promotes angiogenesis in rodent and human endothelial cells

Open access
Min, Jeong-Ki, Park, Hongryeol, Choi, Hyun-Jung, Kim, Yonghak, Pyun, Bo-Jeong, Agrawal, Vijayendra, Song, Byeong-Wook, Jeon, Jongwook, Maeng, Yong-Sun, Rho, Seung-Sik, Shim, Sungbo, Chai, Jin-Ho, Koo, Bon-Kyoung, Hong, Hyo Jeong, Yun, Chae-Ok, Choi, Chulhee, Kim, Young-Myoung, Hwang, Ki-Chul, Kwon, Young-Guen · 2011 · Journal of Clinical Investigation
Cited by 109

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Neovessel formation is a complex process governed by the orchestrated action of multiple factors that regulate EC specification and dynamics within a growing vascular tree. These factors have been widely exploited to develop therapies for angiogenesis-related diseases such as diabetic retinopathy and tumor growth and metastasis. WNT signaling has been implicated in the regulation and development of the vascular system, but the detailed mechanism of this process remains unclear. Here, we report that Dickkopf1 (DKK1) and Dickkopf2 (DKK2), originally known as WNT antagonists, play opposite functional roles in regulating angiogenesis. DKK2 induced during EC morphogenesis promoted angiogenesis in cultured human endothelial cells and in in vivo assays using mice. Its structural homolog, DKK1, suppressed angiogenesis and was repressed upon induction of morphogenesis. Importantly, local injection of DKK2 protein significantly improved tissue repair, with enhanced neovascularization in animal models of both hind limb ischemia and myocardial infarction. We further showed that DKK2 stimulated filopodial dynamics and angiogenic sprouting of ECs via a signaling cascade involving LRP6-mediated APC/Asef2/Cdc42 activation. Thus, our findings demonstrate the distinct functions of DKK1 and DKK2 in controlling angiogenesis and suggest that DKK2 may be a viable therapeutic target in the treatment of ischemic vascular diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci42556

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 109

Metadata

Authors
Min, J.-K., Park, H., Choi, H.-J., Kim, Y., Pyun, B.-J., Agrawal, V., Song, B.-W., Jeon, J., Maeng, Y.-S., Rho, S.-S., Shim, S., Chai, J.-H., Koo, B.-K., Hong, H. J., Yun, C.-O., Choi, C., Kim, Y.-M., Hwang, K.-C., & Kwon, Y.-G.
Venue
Journal of Clinical Investigation
Published
2011-05-02
Volume
121
Issue
5
Pages
1882-1893
ISSN
0021-9738 (ISSN-L)
OpenAlex
W2009193373
Cited by
109
References
10
FWCI
2.70
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The WNT antagonist Dickkopf2 promotes angiogenesis in rodent and human endothelial cells. https://app.cochat.ai/papers/10.1172/jci42556
The paper
Min, J.-K., Park, H., Choi, H.-J., Kim, Y., Pyun, B.-J., Agrawal, V., Song, B.-W., Jeon, J., Maeng, Y.-S., Rho, S.-S., Shim, S., Chai, J.-H., Koo, B.-K., Hong, H. J., Yun, C.-O., Choi, C., Kim, Y.-M., Hwang, K.-C., & Kwon, Y.-G. (2011). The WNT antagonist Dickkopf2 promotes angiogenesis in rodent and human endothelial cells. Journal of Clinical Investigation. https://doi.org/10.1172/jci42556

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.